[[4-[(3-Methylphenyl)amino]-3-pyridinyl]sulfonyl]carbamic Acid Ethyl Ester

[4-[(3-Methylphenyl)amino]-3-pyridinyl]sulfonyl]carbamic Acid Ethyl Ester, also known as MPSPC, is a chemical compound that is commonly used in pharmaceutical research for its potential as a therapeutic agent. The chemical is a white to off-white crystalline powder that has a molecular weight of 365.45 g/mol. MPSPC is a type of sulfonylurea compound, which has been shown to have hypoglycemic effects in animal models. This suggests that MPSPC may have potential as a treatment for type 2 diabetes. Sulfonylureas work by stimulating the release of insulin from pancreatic beta cells, which helps to lower blood glucose levels. In addition to its potential as a therapeutic agent, MPSPC has also been used in research as a tool to study the structure and function of enzymes. Specifically, it has been used as an inhibitor of the enzyme carbonic anhydrase, which plays a role in processes such as acid-base balance and respiration. Overall, MPSPC is a versatile chemical compound that has potential applications in both pharmaceutical research and enzyme studies. Its hypoglycemic effects and inhibition of carbonic anhydrase make it a promising candidate for further investigation and development.